On Jan. 11, Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR), announced that they have agreed to merge to create a new leading global HBV company focused on developing a curative regimen for hepatitis B patients by combining multiple therapeutic approaches. Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) belongs to Healthcare sector. Its weekly performance is 55.49%. On last trading day company shares ended up $22.95. Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) distance from … Continue reading Market Alert: Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR), QUALCOMM, Inc. (NASDAQ:QCOM), ESCO Technologies Inc. (NYSE:ESE), Apollo Commercial Real Estate Finance (NYSE:ARI), ServiceNow, Inc. (NYSE:NOW)